PFIZER INC Short-Term Debt
PFIZER INC (PFE) had Short-Term Debt of $2.70 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-08-04
- 2026-06-28: Debt, Current $2.70B.
- 2026-03-29: Debt, Current $3.89B.
- 2025-12-31: Debt, Current $3.15B.
- 2025-09-28: Debt, Current $4.30B.
| Period end | Debt, Current | Debt, Current as first filed |
|---|---|---|
| 2026-06-28 | $2.70B 10-Q · filed 2026-08-04 | |
| 2026-03-29 | $3.89B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $3.15B 10-Q · filed 2026-08-04 | |
| 2025-09-28 | $4.30B 10-Q · filed 2025-11-04 | |
| 2025-06-29 | $4.29B 10-Q · filed 2025-08-05 | |
| 2025-03-30 | $4.47B 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $6.95B 10-K · filed 2026-02-26 | |
| 2024-09-29 | $9.70B 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $11.94B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $8.23B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $10.35B 10-K · filed 2025-02-27 | |
| 2023-10-01 | $2.55B 10-Q · filed 2023-11-08 | |
| 2023-07-02 | $3.98B 10-Q · filed 2023-08-09 | |
| 2023-04-02 | $4.19B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.94B 10-K · filed 2024-02-22 | |
| 2022-10-02 | $4.04B 10-Q · filed 2022-11-09 | |
| 2022-07-03 | $5.99B 10-Q · filed 2022-08-10 | |
| 2022-04-03 | $645.00M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $2.24B 10-K · filed 2023-02-23 | |
| 2021-10-03 | $3.63B 10-Q · filed 2021-11-12 | |
| 2021-07-04 | $3.89B 10-Q · filed 2021-08-12 | |
| 2021-04-04 | $4.35B 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.70B 10-K · filed 2022-02-24 | |
| 2020-09-27 | $13.36B 10-Q · filed 2020-11-05 | |
| 2020-06-28 | $13.08B 10-Q · filed 2020-08-06 | |
| 2020-03-29 | $16.01B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $16.20B 10-K · filed 2021-02-25 | |
| 2019-09-29 | $16.62B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $10.51B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.41B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $8.83B 10-K · filed 2020-02-27 | |
| 2018-09-30 | $7.38B 10-Q · filed 2018-11-08 | |
| 2018-07-01 | $11.58B 10-Q · filed 2018-08-09 | |
| 2018-04-01 | $9.01B 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $9.95B 10-K · filed 2019-02-28 | |
| 2017-10-01 | $9.45B 10-Q · filed 2017-11-09 | |
| 2017-07-02 | $9.51B 10-Q · filed 2017-08-10 | |
| 2017-04-02 | $7.68B 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $10.69B 10-K · filed 2018-02-22 | |
| 2016-10-02 | $13.63B 10-Q · filed 2016-11-10 | |
| 2016-07-03 | $13.72B 10-Q · filed 2016-08-11 | |
| 2016-04-03 | $11.55B 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $10.16B 10-K · filed 2017-02-23 | $10.16B 10-K · filed 2016-02-29 |
| 2015-09-27 | $9.82B 10-Q · filed 2015-11-05 | |
| 2015-06-28 | $8.39B 10-Q · filed 2015-08-06 | |
| 2015-03-29 | $6.55B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $5.14B 10-K · filed 2016-02-29 | |
| 2014-09-28 | $5.39B 10-Q · filed 2014-11-06 | |
| 2014-06-29 | $5.56B 10-Q · filed 2014-08-07 | |
| 2014-03-30 | $9.32B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $6.03B 10-K · filed 2015-02-27 | |
| 2013-09-29 | $4.74B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $5.21B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $8.90B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $6.42B 10-K · filed 2014-02-28 | |
| 2012-09-30 | $7.77B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $7.70B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $5.53B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.02B 10-K · filed 2013-02-28 | $4.02B 10-K · filed 2012-02-28 |
| 2011-10-02 | $5.64B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $5.99B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $6.09B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $5.60B 10-K · filed 2012-02-28 | $5.62B 10-K · filed 2011-02-28 |
| 2010-10-03 | $5.16B 10-Q · filed 2010-11-12 | |
| 2010-07-04 | $5.51B 10-Q · filed 2010-08-12 | |
| 2010-04-04 | $7.77B 10-Q · filed 2010-05-13 | |
| 2009-12-31 | $5.47B 10-K · filed 2011-02-28 | |
| 2009-09-27 | $6.95B 10-Q · filed 2009-11-05 | |
| 2009-06-28 | $7.64B 10-Q · filed 2009-08-06 | |
| 2008-12-31 | $9.32B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |